TiMELiNES
Everything has a timeline
TiMELiNES
November 2023
United Kingdom authorizes the first CRISPR-based medicine
UK regulators approve a CRISPR therapy for sickle cell disease and beta thalassemia, a landmark for clinical gene editing.
Context
Appears In
Authority
Sources
Taxonomy